Viatris Inc - Company Profile
Powered by 
All the data and insights you need on Viatris Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Viatris Inc Strategy Report
- Understand Viatris Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Business Description
Viatris Inc (Viatris) develops, manufactures, markets and distributes generics, branded medicines, APIs and consumer healthcare products. It markets products for conditions related to respiratory and allergy, cardiovascular, central nervous system, infectious disease, oncology, anesthesia, and others, besides anti-retrovirals and anaphylaxis products.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
R&D Overview
The R&D activities of Viatris focuses on the development, manufacture and commercialization of pharmaceutical products. In FY2022, the company spent US$659.8 million on R&D, which as a percentage of revenue, stood at 4.05%. It has R&D collaboration with Momenta Pharmaceuticals, Biocon Ltd, Theravance Biopharma Inc, and Fujifilm Kyowa Kirin Biologics Co Ltd. The company's R&D centers include two global R&D centers and ten technology-focused development sites. Owns numerous US and foreign patents covering certain products. It has more than 35,000 trademarks filed globally. It also developed brand names and trademarks for other products.
Product Categories
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Geographical Segments
Overview
Major brands include Lyrica, Lipitor, Wixela Inhub, Creon, Influvac, and EpiPen. Believes that launch of new products is a vital part of its growth strategy.
Target Markets
North America and Europe.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Overview
Comprises operations of anti-retroviral franchise.
Target Markets
Includes operations in countries with developing markets and emerging economies in Asia, South and Central America, Africa, the Middle East and Eastern Europe.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Overview
Comprises branded loss of exclusivity(LOE) products. Major brands include Lipitor, Norvasc, and Viagra.
Target Markets
China, Taiwan and Hong Kong.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Overview
Major brands include AMITIZA, Lipacreon, Lyrica, Norvasc, and Effexor. Believes that launch of new products is a vital part of the company's growth strategy.
Target Markets
Japan, Australia and New Zealand.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer